Stay updated with breaking news from Eric Lefebvre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) has earned a consensus rating of “Buy” from the eleven brokerages that are currently covering the firm, Marketbeat Ratings reports. Eleven investment analysts have rated the stock with a buy rating. The average 12-month price target among brokers that have updated their coverage on the stock in […]
KRONEN was originally founded in 1978. In 1998, Rudolf Hans Zillgith took over the company’s business division of machines for the salad, fruit and vegetable industry and took the helm as its Managing Director.
/cloudfront-us-east-1.images.arcpublishing.com/tgam/LTYCFFJM2VDJXBIKNWUXWIYZJA)
A roundup of investment ideas for active investors
/cloudfront-us-east-1.images.arcpublishing.com/tgam/3KQKYWLKNRGZVA5E6ODFOHEV5Q.jpg)
The company has expanded from its roots as a Canadian food-court operator to a global franchiser with a diversified portfolio of fast-food and casual-dining restaurants
Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) insider Eric Lefebvre sold 22,321 shares of the firm’s stock in a transaction that occurred on Monday, July 17th. The shares were sold at an average price of $18.01, for a total transaction of $402,001.21. Following the completion of the sale, the insider now owns 167,215 shares […]